Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wittes

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|April 29, 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing DialysisKai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, et al.
Plos One|March 6, 2009
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western KenyaBernhards R Ogutu, Odika J Apollo, Denise McKinney, et al.
Journal of the American College of Cardiology|November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
The New England Journal of Medicine|April 29, 2021
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKDGlenn M Chertow, Pablo E Pergola, Youssef M K Farag, et al.
JAMA|June 21, 2021
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 StatementAaron M Orkin, Peter J Gill, Davina Ghersi, et al.
Lancet (London, England)|July 18, 2017
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trialStephen Russell, Jean Bennett, Jennifer A Wellman, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Vaccine|March 10, 2005
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of ResearchD Gray Heppner, Kent E Kester, Christian F Ockenhouse, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|April 29, 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing DialysisKai-Uwe Eckardt, Rajiv Agarwal, Ahmad Aswad, et al.
Plos One|March 6, 2009
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western KenyaBernhards R Ogutu, Odika J Apollo, Denise McKinney, et al.
Journal of the American College of Cardiology|November 13, 2020
Conduct of Clinical Trials in the Era of COVID-19: JACC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
JAMA|December 4, 2020
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical TrialOrly Vardeny, KyungMann Kim, Jacob A Udell, et al.
The New England Journal of Medicine|April 29, 2021
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKDGlenn M Chertow, Pablo E Pergola, Youssef M K Farag, et al.
JAMA|June 21, 2021
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances: The CONSERVE 2021 StatementAaron M Orkin, Peter J Gill, Davina Ghersi, et al.
Lancet (London, England)|July 18, 2017
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trialStephen Russell, Jean Bennett, Jennifer A Wellman, et al.
European Heart Journal|June 5, 2020
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Stefan D Anker, Javed Butler, Muhammad Shahzeb Khan, et al.
European Heart Journal|April 22, 2017
Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpointsPatrick Rossignol, Rajiv Agarwal, Bernard Canaud, et al.
Vaccine|March 10, 2005
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of ResearchD Gray Heppner, Kent E Kester, Christian F Ockenhouse, et al.
Pageof 13